Regen Biopharma, Inc.

$rgbp Chart Analysis

139
upon review bullish divergence can be seen when combining rsi with price action
mac d is coming to retest

candles give off sign we''ve hit the bottom

huge buy of 30k today

descending triangle spotted that may break up or down

The Barchart Technical Opinion rating is a 72% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

be careful trading against trends

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。